Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about EYPT
Recent news which mentions EYPT
< Previous
1
2
3
4
Next >
Earnings Preview: EyePoint Pharmaceuticals
March 01, 2023
Tickers
EYPT
Tags
BZI/EP
Benzinga
Earnings
From
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
February 03, 2023
Tickers
AWH
CTSO
EYPT
HSCS
Tags
CTSO
Market News
BZI/TFM
From
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
January 12, 2023
Tickers
DRTS
ENSC
EYPT
FWBI
Tags
JAGX
DRTS
Market News
From
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
November 30, 2022
Tickers
AAP
AIM
AKLI
ALTO
Tags
FHTX
VXRT
BOXD
From
Benzinga
AiViva Reports That Their Promising New Treatment For Wet AMD Is Soon To Be Ready For Clinical Trials
November 14, 2022
Tickers
AERI
CLSD
EYPT
GRAY
Tags
Partner Content
AERI
Market News
From
Benzinga
EyePoint Pharmaceuticals: Q3 Earnings Insights
November 02, 2022
Tickers
EYPT
Tags
Benzinga
BZI/Recaps
EYPT
From
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
October 05, 2022
Tickers
ARTW
ARVL
ATER
ATXG
Tags
SMG
ATXG
HIW
From
Benzinga
Meet The Company Bringing New Treatments For Serious Eye Issues To Market
October 05, 2022
Tickers
EYPT
Tags
Interview
Eyepoint Pharmaceuticals
Biotech
From
Benzinga
Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial
August 03, 2022
Tickers
ALNY
AMRN
ARQT
BMRN
Tags
RIGL
Biotech
Penny Stocks
From
Benzinga
Recap: EyePoint Pharmaceuticals Q2 Earnings
August 03, 2022
Tickers
EYPT
Tags
Market News
EYPT
Earnings
From
Benzinga
Earnings Preview For EyePoint Pharmaceuticals
August 02, 2022
Tickers
EYPT
Tags
Benzinga
BZI/EP
Earnings
From
Benzinga
Recap of Monday's Biotech Catalysts - End of the Day Summary
July 18, 2022
Tickers
ABBV
ACAD
ACER
APYX
Tags
RYTM
Health Care
APYX
From
Benzinga
Why Bank Stocks Traded Sharply Higher; Here's 65 Biggest Movers From Friday
July 18, 2022
Tickers
ADVM
AOUT
AREB
ATIP
Tags
CDXS
XRTX
SPB
From
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
July 15, 2022
Tickers
ATIP
BIMI
CDXS
EVFM
Tags
MSPR
VIGL
BIMI
From
Benzinga
EyePoint Announces Positive Safety and Efficacy Data From Initial-Stage Wet AMD Study
July 15, 2022
Tickers
EYPT
Tags
General
Benzinga
Small Cap
From
Benzinga
EyePoint Pharma Posts 12-Month Safety, Efficacy Data From Early-Stage Wet AMD Trial
July 15, 2022
Tickers
EYPT
Tags
Benzinga
General
News
From
Benzinga
7 Wildly Oversold Nasdaq Stocks to Buy Now
July 12, 2022
Tickers
ARBK
CAR
CGC
EYPT
Tags
CGC
Stocks to Buy
CAR
From
InvestorPlace
Chardan Forecasts Over 160% Upside On This Eye Disease-Focused Stock
July 07, 2022
Tickers
EYPT
Tags
Analyst Color
Initiation
Briefs
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 7, 2022
July 07, 2022
Tickers
ABTX
ADVM
ALEC
AMTI
Tags
OTIS
SGC
ADVM
From
Benzinga
Recap of Tuesday's Biotech Catalysts - End of the Day Summary
June 21, 2022
Tickers
ABBV
ACER
ARDX
CLDX
Tags
General
Market News
biotech catalysts
From
Benzinga
EyePoint, Expands Pact With Betta Pharma For EYP-1901 In China, Posts Deeper Q1 Loss
May 04, 2022
Tickers
EYPT
Tags
Small Cap
Benzinga
EYPT
From
Benzinga
Recap: EyePoint Pharmaceuticals Q1 Earnings
May 04, 2022
Tickers
EYPT
Tags
Benzinga
BZI/Recaps
EYPT
From
Benzinga
EyePoint Pharmaceuticals Earnings Conference Call Is Coming Up, Here's What You Need To Know
April 28, 2022
Tickers
EYPT
Tags
News
EYPT
Market News
From
Benzinga
EyePoint Pharma Secures $45M Credit Facilities For Debt Refinancing
March 09, 2022
Tickers
EYPT
Tags
Briefs
Biotech
Health Care
From
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
March 03, 2022
Tickers
ATNX
CTIC
DBVT
EAR
Tags
ZLAB
EAR
DBVT
From
Benzinga
Recap: EyePoint Pharmaceuticals Q4 Earnings
March 03, 2022
Tickers
EYPT
Tags
Benzinga
BZI/Recaps
News
From
Benzinga
Earnings Scheduled For March 3, 2022
March 03, 2022
Tickers
ABUS
ACR
ADCT
ADTH
Tags
MCS
PASG
ONCY
From
Benzinga
Earnings Preview: EyePoint Pharmaceuticals
March 02, 2022
Tickers
EYPT
Tags
Benzinga
BZI/EP
Market News
From
Benzinga
The Daily Biotech Pulse: Valneva Strikes Deal To Supply COVID Vaccine to Bahrain, TherapeuticsMD & Amneal Settle Patent Lawsuit, Reata Awaits Adcom
December 08, 2021
Tickers
ACET
AMAM
AMRX
BIIB
Tags
TXMD
AMAM
Offerings
From
Benzinga
61 Biggest Movers From Yesterday
November 18, 2021
Tickers
AN
ANET
APWC
ARVL
Tags
COCO
Penny Stocks
IONQ
From
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.